C12N 2501/105
Insulin-like growth factors [igf]
Official title: Insulin-like growth factors [IGF]
C12N2501/105 (Insulin-like growth factors [igf]) appears on 428 US grants and 858 published applications in this corpus.
Search patents in C12N- Granted patents
- 428
- Published applications
- 858
- Assignees
- 456
- Inventors
- 1,440
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 8 | 0 |
| 2001 | 0 | 1 |
| 2002 | 6 | 23 |
| 2003 | 12 | 17 |
| 2004 | 6 | 17 |
| 2005 | 6 | 32 |
| 2006 | 9 | 24 |
| 2007 | 13 | 19 |
| 2008 | 6 | 25 |
| 2009 | 5 | 30 |
| 2010 | 15 | 32 |
| 2011 | 16 | 33 |
| 2012 | 22 | 33 |
| 2013 | 14 | 25 |
| 2014 | 20 | 31 |
| 2015 | 23 | 30 |
| 2016 | 26 | 41 |
| 2017 | 25 | 38 |
| 2018 | 27 | 30 |
| 2019 | 16 | 35 |
| 2020 | 26 | 49 |
| 2021 | 13 | 38 |
| 2022 | 20 | 49 |
| 2023 | 17 | 54 |
| 2024 | 27 | 62 |
| 2025 | 22 | 54 |
| 2026 | 15 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Method for the in vitro or ex vivo amplification of human adipose tissue stem cells1 Sep 2026US 12,723,234 B2Centre National de la Recherche Scientifique (CNRS)
- Method of in vitro chondrocyte and cartilage culture to obtain material for the treatment of articular cartilage defects25 Aug 2026US 12,714,766 B2Arthec S.A.
- Maturation medium compositions and methods for human heart organoid maturation17 Sep 2026US 2026/0275292 A1Board of Trustees of Michigan State University
- Method for isolating hemogenic endothelial cells3 Sep 2026US 2026/0258361 A1Fondazione Telethon Ets
- Induction/differentiation medium for producing of mesenchymal stem cells and application thereof3 Sep 2026US 2026/0258367 A1Hunan Meibo Biomedical Co., Ltd
- Development of cell medium and feed on mammalian cells27 Aug 2026US 2026/0250741 A1Evonik Operations GmbH
- Cd4 + and cd8 + single positive t cells and compositions and methods for generating the same20 Aug 2026US 2026/0242728 A1Clade Therpaeutics, Inc.
Most cited
By later US patents
- Human CNS neural stem cells194US 5,968,829 ACytoTherapeutics, Inc. · 1999
- Chondrocyte media formulations and culture procedures192US 6,150,163 AGenzyme Corporation · 2000
- Chemically defined medium for human mesenchymal stem cells174US 5,908,782 AOsiris Therapeutics, Inc. · 1999
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Methods of producing pancreatic hormones165US 7,534,608 B2Cythera, Inc. · 2009